CXCL8 and neoplasm: After ICI initiation, the antibiotic-treated group also sustained greater increases in IL-8/CXCL8, a chemokine involved in myeloid leukocyte migration and neutrophil degranulation that is also associated with tumor progression and reduced benefit from immune checkpoint blockade in prior studies [9,11,51,52] and in the present analysis.